We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTO
1826
H2O America
HTO
$2.59B
| $1.48M | ﹤0.01% |
26,547
+7,488
| +39% | +$444K |
|
1827
KLX Energy Services
KLXE
$44.2M
| $1.47M | ﹤0.01% |
12,560
+1,852
| +17% | +$257K |
|
|
HIFR
1828
DELISTED
InfraREIT, Inc.
HIFR
| $1.46M | ﹤0.01% |
69,602
+18,950
| +37% | +$404K |
|
|
MRC
1829
DELISTED
MRC Global
MRC
| $1.46M | ﹤0.01% |
119,259
+35,519
| +42% | +$562K |
|
|
ESPR
1830
DELISTED
Esperion Therapeutics
ESPR
| $1.45M | ﹤0.01% |
31,583
+9,836
| +45% | +$474K |
|
1831
AtriCure
ATRC
$2.01B
| $1.44M | ﹤0.01% |
47,144
+16,725
| +55% | +$521K |
|
1832
Arrowhead Research
ARWR
$12.1B
| $1.44M | ﹤0.01% |
115,963
+37,148
| +47% | +$508K |
|
|
VBTX
1833
DELISTED
Veritex Holdings
VBTX
| $1.44M | ﹤0.01% |
67,238
+44,731
| +199% | +$1.09M |
|
|
LABL
1834
DELISTED
Multi-Color Corp
LABL
| $1.44M | ﹤0.01% |
40,894
+6,737
| +20% | +$319K |
|
1835
Carvana
CVNA
$75.1B
| $1.43M | ﹤0.01% |
218,820
+72,375
| +49% | +$609K |
|
1836
Opko Health
OPK
$985M
| $1.43M | ﹤0.01% |
475,850
+137,968
| +41% | +$468K |
|
|
WSR
1837
DELISTED
Whitestone REIT
WSR
| $1.43M | ﹤0.01% |
116,762
+19,558
| +20% | +$265K |
|
1838
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
| $1.43M | ﹤0.01% |
75,036
+22,058
| +42% | +$476K |
|
1839
Matrix Service
MTRX
$330M
| $1.43M | ﹤0.01% |
79,632
+14,038
| +21% | +$287K |
|
1840
Theravance Biopharma
TBPH
$877M
| $1.43M | ﹤0.01% |
55,783
+18,752
| +51% | +$506K |
|
|
BNCL
1841
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $1.43M | ﹤0.01% |
99,827
+32,046
| +47% | +$496K |
|
|
DENN
1842
DELISTED
Denny's
DENN
| $1.43M | ﹤0.01% |
87,920
+27,290
| +45% | +$429K |
|
1843
Kinsale Capital Group
KNSL
$8.57B
| $1.42M | ﹤0.01% |
25,615
+8,301
| +48% | +$491K |
|
|
IPHS
1844
DELISTED
Innophos Holdings, Inc.
IPHS
| $1.42M | ﹤0.01% |
57,933
+9,794
| +20% | +$298K |
|
1845
Anika Therapeutics
ANIK
$270M
| $1.42M | ﹤0.01% |
42,172
+6,080
| +17% | +$219K |
|
1846
Artisan Partners
APAM
$3.06B
| $1.42M | ﹤0.01% |
63,991
+20,236
| +46% | +$540K |
|
1847
First Bancorp
FBNC
$2.66B
| $1.41M | ﹤0.01% |
43,283
+12,448
| +40% | +$465K |
|
|
FFG
1848
DELISTED
FBL Financial Group
FFG
| $1.41M | ﹤0.01% |
21,394
+4,157
| +24% | +$291K |
|
1849
Quanex
NX
$959M
| $1.4M | ﹤0.01% |
103,223
+17,583
| +21% | +$268K |
|
1850
BancFirst
BANF
$3.81B
| $1.4M | ﹤0.01% |
28,099
+7,677
| +38% | +$427K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.